Key figures

Key financial figures from 2008 to 2012.

(DKK million)​ ​2012 2011​ 2010​ ​2009 ​2008
Group sales
 ​11,234 10,510​ 9,724​
8,448
8,146
 - Household Care Enzymes
 ​3,780
3,325 ​
3,151
2,672
2,498
 - Food & Beverages Enzymes
 ​​3,186
3,033 ​​
 2,850​
2,466
2,423
 - Bioenergy Enzymes
 1,​748
1,782 ​​
 1,846
1,480
1,389
 - Feed & Other Technical Enzymes
 ​​1,449
1,349 ​​
 1,262​
1,180 
1,223 
 - Microorganisms
 ​​944
767 ​​
 429​
415
405
 - Biopharma
 ​127
254 ​​
 186​
235
208
Gross profit
 6,423​ 5,908​ 5,412​
4,700
4,359
EBITDA
 ​3,448​ 3,126​ 2,796​
2,252
2,060
EBIT
 ​2,745​ 2,340​ 2,117​
1,688
1,504
Net profit
 ​2,016​ 1,828​ 1,614​
1,194
1,062
Operating cash flow
 2,758 2,709​ 2,324​
1,817
1,697
Net invest. before acq.
 ​(1,177) (1,316)​ (1,326)​
(978)
(942)
Free cash flow before acq.
 ​1,581​ 1,393​ 998​
839
755
Net acquisitions
 ​(732​) (1,426)​ (23)​
-
-
Free cash flow
 ​849 (33)​ 975​
839
755
Total assets
 ​15,113​ 13,842​ 12,593​
10,890
9,925
Net interest-bearing debt
 ​1,430​ 1,019​ 346​
949
1,380
EPS (diluted), DKK 
 ​6.33 5.71​ 5.05​
3.79
3.37 
 
 ​ ​ ​
 
 
(%)
 ​ ​ ​
 
 
Sales growth
 ​6.9 8.1​ 15.1​
3.7
9.5
Gross margin
 ​57.2 56.2​ 55.7​
55.6
53.5
EBITDA margin
 ​30.7 29.7​ 28.8​
26.7
25.3
EBIT margin
 24.4​ 22.3​ 21.8​
20.0
18.5
Return on equity
 ​21.9 21.9​ 23.6​
23.1
26.1
ROIC, incl. goodwill
 ​19.9 21.3​ 22.2​
20.3
19.5
R&D/sales
 ​13.6 14.0​ 14.0​
14.3
13.5
Net investments before acq./sales
 ​10.5 12.5​ 13.6​
11.6
11.6
FCF before acq./sales
 ​14.1 13.3​ 10.3​
9.9
9.3
Net debt-to-equity
 ​14.9 11.5​ 4.4​
16.2
30.8
Equity ratio
 ​63.3 63.7​ 62.2​
53.6
45.1